Study confirms efficacy of combination therapy in patients with stage III melanoma

The majority of melanomas are diagnosed at an early stage, however, some patients present for medical care at a late

Calcipotriol/betamethasone dipropionate FDC ‘dominates’ other treatments

Psoriasis severity measures The 2021 American Academy of Dermatology (AAD) guideline recommends body surface area (BSA) to assess the severity

Is sequential treatment of dyslipidaemia effective in clinical practice?

Presentation by Prof Evangelos Liberopoulos of the University of Ioannina (Greece) at the virtual European Society of Cardiology (ESC) congress held from 27-30 August.

Specialist Forum October 2021 issue CPDs

Allergic rhinitis + asthma = united airways disease Childhood allergic rhinitis (AR), an immunoglobulin (Ig) E-mediated condition, usually caused by

Superior HbA1c reduction with Solimix

Guidelines recommend progressive addition of rapid-acting insulin to patients’ existing basal insulin regimen, multiple doses of premix insulin, the addition

Preventing sudden death in patients with heart failure

The prevalence of HF has been steadily increasing over the last few years and currently affect between 1% and 2%

Allergic rhinitis + asthma = united airways disease

Kaplan et al2 found that 59%-78% of children with asthma also have rhinitis and Giavina-Bianchi et al5 showed that between

PAF goes allergic rhinitis

Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC), which included standardised and validated questionnaires for

Why skin barrier protection is important

Twice-daily, liberal application of moisturisers on lesioned and non-lesioned skin is the bedrock of atopic dermatitis (AD) management, as recommended by international guidelines.

Fusidic acid – first-choice option in the treatment of skin infection

The majority of skin infections tend to be mild and generally resolve within seven to 10 days.

Is generic substitution in NTIDs ethical?

Generic substitution is advocated worldwide to reduce healthcare-related costs.

Managing dysphagia in patients with schizophrenia

A study showed a reduction in life expectancy of 18.7 years for men and 16.3 years for women with schizophrenia.